These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 17514206)
1. All roads lead to CARD9. Colonna M Nat Immunol; 2007 Jun; 8(6):554-5. PubMed ID: 17514206 [No Abstract] [Full Text] [Related]
2. CARD9 signaling in the innate immune response. Ruland J Ann N Y Acad Sci; 2008 Nov; 1143():35-44. PubMed ID: 19076343 [TBL] [Abstract][Full Text] [Related]
3. A pair of 9s: it's in the CARDs. Underhill DM; Shimada T Nat Immunol; 2007 Feb; 8(2):122-4. PubMed ID: 17242682 [TBL] [Abstract][Full Text] [Related]
4. CARD9 versus CARMA1 in innate and adaptive immunity. Hara H; Saito T Trends Immunol; 2009 May; 30(5):234-42. PubMed ID: 19359218 [TBL] [Abstract][Full Text] [Related]
5. CARD6 is interferon inducible but not involved in nucleotide-binding oligomerization domain protein signaling leading to NF-kappaB activation. Dufner A; Duncan GS; Wakeham A; Elford AR; Hall HT; Ohashi PS; Mak TW Mol Cell Biol; 2008 Mar; 28(5):1541-52. PubMed ID: 18160713 [TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor and RIG-I-like receptor signaling. Kawai T; Akira S Ann N Y Acad Sci; 2008 Nov; 1143():1-20. PubMed ID: 19076341 [TBL] [Abstract][Full Text] [Related]
10. The Role of CARD9 Deficiency in Neutrophils. Sheng R; Zhong X; Yang Z; Wang X Mediators Inflamm; 2021; 2021():6643603. PubMed ID: 33488294 [TBL] [Abstract][Full Text] [Related]
11. Recent insights into the structure of Toll-like receptors and post-translational modifications of their associated signalling proteins. Carpenter S; O'Neill LA Biochem J; 2009 Jul; 422(1):1-10. PubMed ID: 19627256 [TBL] [Abstract][Full Text] [Related]
12. Revisiting an old acquaintance: CD26 and its molecular mechanisms in T cell function. Ohnuma K; Dang NH; Morimoto C Trends Immunol; 2008 Jun; 29(6):295-301. PubMed ID: 18456553 [TBL] [Abstract][Full Text] [Related]
13. Generation and functional characterization of a BCL10-inhibitory peptide that represses NF-kappaB activation. Marasco D; Stilo R; Sandomenico A; Monti SM; Tizzano B; de Capua A; Varricchio E; Liguoro D; Zotti T; Formisano S; Ruvo M; Vito P Biochem J; 2009 Aug; 422(3):553-61. PubMed ID: 19538180 [TBL] [Abstract][Full Text] [Related]
14. Editorial: CARMA Proteins: Playing a Hand of Four CARDs. Bornancin F; Snow AL Front Immunol; 2019; 10():1217. PubMed ID: 31231375 [No Abstract] [Full Text] [Related]
15. TLRs in the Gut. IV. Negative regulation of Toll-like receptors and intestinal homeostasis: addition by subtraction. Shibolet O; Podolsky DK Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1469-73. PubMed ID: 17554134 [TBL] [Abstract][Full Text] [Related]
16. [Signal transduction by protein tyrosine kinases and antitumor agents]. Mao YJ; Li HH; Li JF; Shen JS Yao Xue Xue Bao; 2008 Apr; 43(4):323-34. PubMed ID: 18664191 [TBL] [Abstract][Full Text] [Related]
19. When signaling pathways collide: positive and negative regulation of toll-like receptor signal transduction. O'Neill LA Immunity; 2008 Jul; 29(1):12-20. PubMed ID: 18631453 [TBL] [Abstract][Full Text] [Related]
20. Distinct intracellular signaling pathways control the synthesis of IL-8 and RANTES in TLR1/TLR2, TLR3 or NOD1 activated human airway epithelial cells. Bérubé J; Bourdon C; Yao Y; Rousseau S Cell Signal; 2009 Mar; 21(3):448-56. PubMed ID: 19121387 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]